carbenoxolone sodium has been researched along with acrolein in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, J; Gao, S; Huang, Y; Kamiyama, M; Koizumi, S; Mitsui, T; Takeda, M; Tanaka, M; Yao, J; Zhang, X; Zhang, Z | 1 |
1 other study(ies) available for carbenoxolone sodium and acrolein
Article | Year |
---|---|
Carbenoxolone inhibits TRPV4 channel-initiated oxidative urothelial injury and ameliorates cyclophosphamide-induced bladder dysfunction.
Topics: Acrolein; Animals; Calcium; Carbenoxolone; Cyclophosphamide; Cystitis; Enzyme Activation; Female; Mice, Inbred C57BL; Oxidation-Reduction; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; TRPV Cation Channels; Urinary Bladder; Urothelium | 2017 |